Regeneron Pharmaceuticals News — every source, one live feed

Track Regeneron Pharmaceuticals news in real time — S&P 500 — biotechnology, REGN. fllwup^ collects the latest Regeneron Pharmaceuticals headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.

Latest Regeneron Pharmaceuticals headlines

  • Regeneron Pharmaceuticals, Inc. (REGN) Stock Forecasts — Yahoo Finance
  • Regeneron, Alnylam win FDA nod for myasthenia gravis therapy — Seeking Alpha
  • FDA Approval Could Be A Big Moment For Regeneron Stock (REGN) — Simply Wall St
  • Regeneron (REGN) stock trades up, here is why — Yahoo Finance
  • The day after exercising options on 17,000 Regeneron (REGN) shares, Andrew J. Murphy sold stock. — Stock Titan
  • Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Has Average Target Price of $904.41 — MarketBeat
  • Does Flexible Libtayo Dosing Change The Bull Case For Regeneron Pharmaceuticals Stock? — Yahoo Finance
  • REGN Stock Drop: Regeneron Clinical Trials Lead to 9% Stock Drop and Securities Fraud Class Action for Investors — PR Newswire
  • Regeneron (REGN) Stock May Trade At A Discount Following Strong Q3 Earnings — Simply Wall St
  • Evaluating Bullish Potential in Regeneron Pharmaceuticals (REGN) Stock — Yahoo Finance

Follow Regeneron Pharmaceuticals live on fllwup^ · Follow in any RSS reader — or browse all topics.

Also tracking

More S&P 500 — Healthcare: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.